| |
| |
|
| Insider
Information: |
Lamattina John L |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
512,782 |
|
|
Indirect Shares
|
59,053 |
|
|
| Direct
Value |
$15,912,160 |
|
|
|
Indirect Value
|
$1,669,428 |
|
|
| Total
Shares |
571,835 |
|
|
| Total
Value |
$17,581,589 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -56.8%
|
-36.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Senior Vice President |
2007-06-29 |
383,190 |
2007-06-29 |
59,053 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Director |
2004-03-09 |
3,000 |
2004-03-09 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-11-12 |
0 |
Premium* |
|
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2023-06-09 |
28,263 |
2011-02-07 |
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director |
2019-01-24 |
31,376 |
2017-02-13 |
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-01-15 |
66,953 |
2020-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Senior Vice PresidentOfficer |
• – – |
2004-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
281,115 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice PresidentOfficer |
• – – |
2004-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
63,272 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-02-26 |
4 |
D |
$37.15 |
$209,266 |
D/D |
(5,633) |
293,488 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
17,910 |
299,121 |
|
- |
|
| TMO |
Thermo Fisher Scientific |
Director |
– • – |
2004-03-09 |
4 |
OE |
$18.86 |
$18,860 |
D/D |
1,000 |
3,000 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
29,850 |
324,257 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-06-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,216 |
12,298 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,216 |
323,041 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
608 |
323,603 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-06-18 |
4 |
OE |
$5.71 |
$34,671 |
D/D |
6,072 |
330,076 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-11-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,300 |
327,236 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2004-11-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
326,736 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2005-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
61,440 |
389,032 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2005-02-24 |
4 |
D |
$26.20 |
$567,256 |
D/D |
(21,651) |
367,381 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2005-05-06 |
4 |
S |
$27.81 |
$1,106,564 |
D/D |
(39,789) |
329,302 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2005-11-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,200 |
327,567 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
85,440 |
415,200 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-02-27 |
4 |
D |
$26.55 |
$60,401 |
D/D |
(2,275) |
412,925 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-04-07 |
4 |
D |
$26.05 |
$729 |
D/D |
(28) |
412,963 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2006-11-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,200 |
418,145 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-07 |
4 |
S |
$26.54 |
$366,252 |
D/D |
(13,800) |
421,101 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-07 |
4 |
OE |
$18.35 |
$253,230 |
D/D |
13,800 |
434,901 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-22 |
4 |
D |
$25.87 |
$516,727 |
D/D |
(19,974) |
475,158 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
73,770 |
495,132 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-03-23 |
4 |
D |
$25.66 |
$351,799 |
D/D |
(13,710) |
461,822 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
